CAMBRIDGE, Mass.--(BUSINESS WIRE)--Feb 27, 2013--MedPanel LLC today announced the launch of MedPanel Capital Advisors (“MPA”), a new business unit within MedPanel. MPA works with established and emerging companies in the biotechnology, medical technology, and diagnostics sectors to advise them on achieving their strategic objectives in capital raising, M&A, and business partnering transactions.
MPA is led by Managing Director Hunt Henrie, who brings to MPA over 25 years of experience operating, investing in, advising on, and structuring transactions in the life science industry. Henrie will also join MedPanel’s Board of Directors and serve as MedPanel’s Executive Vice President.
“The launch of MPA starts an exciting new chapter for MedPanel, enabling us to leverage our Insights business and the extensive set of client relationships we’ve developed to provide essential additional strategic services to our clients,” said Howard Brick, CEO of MedPanel. “I am particularly thrilled that Hunt Henrie will head up this new effort, given his stellar reputation for expertise and integrity in the life science financing and strategic transactional market.” “Bringing my carefully developed network and practice to MedPanel to build a leading advisory services firm for the emerging-companies sector of the life science industry is an exciting professional opportunity for me,” added Henrie. “By partnering with the MedPanel Insights business, I believe we will provide a differentiated advisory services solution that will enable us to achieve the best possible results for our clients.” MPA will utilize the research resources of the MedPanel Insights group to interact with the MedPanel community of tens of thousands of medical and healthcare experts in order to generate robust and credible market insights that will support its capital raising and strategic transactional objectives for clients. MedPanel Insights will continue to ensure that the research it produces for its life science industry clients will remain strictly proprietary and accessible only to its client for whom the research is generated.
Also, in connection with the launch of MPA, MedPanel has signed a Collaboration Agreement with Ferghana Partners, a global firm providing transaction services to life science companies. Under this collaboration, the companies will pool resources to offer integrated advisory services for companies raising capital through private placements and PIPES, and utilize the MedPanel primary research platform for market research services for clients.
MedPanel, LLC, based in Cambridge, Mass., provides corporate financial transaction advisory services to emerging life science companies and market insights to corporate and financial clients in the healthcare industry. Its team of experienced transaction advisors provide strategic advice and direction in guiding clients in achieving its financing, M&A, and strategic partnering objectives. Its seasoned research staff understands the unique complexities and types of decisions MedPanel Insights supports. Its domain expertise, global network of experts, and proven online methods all combine to help our clients make better decisions at every stage of the product life cycle, from inception of an innovative idea to post-launch and beyond. www.medpanel.com
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Feb 27, 2013--MedPanel LLC today announced the launch of MedPanel Capital Advisors (“MPA”), a new business unit within MedPanel. MPA works with established and emerging companies in the biotechnology, medical technology, and...